AI Article Synopsis
- Some thionamide compounds, like methimazole, are used to inhibit thyroid functions and treat hyperthyroidism but can have significant side effects.
- These drugs interfere with lactoperoxidase, disrupting antibacterial activity in exocrine gland secretions and exacerbating gastric issues, contributing to ulcers and impaired wound healing.
- Thionamides can also lead to severe blood and immune system disorders, affecting senses such as smell and hearing, and altering gene expression in certain cells.
Article Abstract
Some compounds having thionamide structure inhibit thyroid functions. Such antithyroid thionamides include mercaptomethylimidazole (methimazole), thiourea and propylthiouracil, of which mercaptomethylimidazole is widely used to treat hyperthyroidism. Undesirable side effects develop from these drugs due to extrathyroidal actions. Antithyroid thionamides inhibit lactoperoxidase which contributes to the antibacterial activities of a number of mammalian exocrine gland secretions that protect a variety of mucosal surfaces. These drugs stimulate both gastric acid and pepsinogen secretions, thereby augmenting the severity of gastric ulcers and preventing wound healing. Increased gastric acid secretion is partially due to the H2 receptor activation, and also through the stimulation of the parietal cell by intracellular generation of H2O2 following inactivation of the gastric peroxidase-catalase system. Severe abnormalities may develop in blood cells and the immune system after thionamide therapy. It causes agranulocytosis, aplastic anemia, and purpura along with immune suppression. Olfactory and auditory systems are also affected by these drugs. Thionamide affects the sense of smell and taste and also causes loss of hearing. It binds to the Bowman's glands in the olfactory mucosa and causes extensive lesion in the olfactory mucosa. Thionamides also affect gene expression and modulate the functions of some cell types. A brief account of the chemistry and metabolism of antithyroid thionamides, along with their biological actions are presented.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0378-4274(01)00539-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Liver Dysfunction in a Patient with Graves' Disease.
J Clin Med
November 2024
Section of Endocrinology and Investigative Medicine, Imperial College London, London W12 ONN, UK.
Liver dysfunction can occur in patients presenting with thyrotoxicosis, due to several different aetiologies. A 42-year-old man had mild liver dysfunction on presentation with hyperthyroidism due to Graves' disease (GD): ALT 65 (0-45 IU/L), fT4 41.2 (9-23 pmol/L), fT3 > 30.
View Article and Find Full Text PDFAn unusual case of severe hyperbilirubinemia and thyrotoxicosis.
Endocr Regul
January 2024
Department of General Medicine, Baroda Medical College and SSG Hospital, Vadodara, India.
Article Synopsis
- - A 23-year-old pregnant woman experienced severe jaundice, anemia, dyspnea, and hyperthyroidism after five months of not menstruating.
- - Initial treatments for jaundice were ineffective, leading to a focus on managing her thyroid storm, a serious condition related to hyperthyroidism.
- - The patient's liver dysfunction improved significantly with the use of iodine and thionamides, highlighting a rare link between severe jaundice and thyroid storm during pregnancy.
Preoperative Preparation in Hyperthyroidism and Surgery in the Hyperthyroid State.
Sisli Etfal Hastan Tip Bul
September 2024
Department of General Surgery, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Hyperthyroidism is a clinical condition that develops due to the excessive production and secretion of thyroid hormones by the thyroid gland, leading to an elevated concentration of thyroid hormones in tissues. Hyperthyroidism is characterized by low TSH and elevated T3 and/or T4, with the most common causes being Graves' disease, toxic multinodular goiter, and solitary toxic adenoma. T3 is the peripherally active form of thyroid hormone, affecting nearly each tissue and system.
View Article and Find Full Text PDFLong-Term Antithyroid Drug Therapy in Smoldering or Fluctuating-Type Graves' Hyperthyroidism with Potassium Iodide.
Endocrinol Metab (Seoul)
December 2024
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Graves' hyperthyroidism is characterized by stimulation of the thyroid gland by thyroid-stimulating hormone receptor antibodies (TRAbs). Antithyroid drug (ATD) continuation is recommended as long as the thyroid gland is stimulated. Goiter size, thyroidal 123I uptake, serum thyroglobulin level, and TRAb positivity are reliable markers of thyroid stimulation.
View Article and Find Full Text PDFGraves' hyperthyroidism treated with potassium iodide: early response and after 2 years of follow-up.
Eur Thyroid J
December 2024
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka, Japan.
Article Synopsis
- A study re-evaluated potassium iodide (KI) therapy for treating Graves' hyperthyroidism (GD) due to adverse effects linked to thionamide medications.
- 324 untreated GD patients were given 100 mg/day of KI, and results showed a significant decrease in thyroid hormone levels within weeks, with over 50% of patients maintained on KI remaining well-controlled over two years.
- No adverse effects were reported from KI, highlighting its effectiveness as a treatment option, with 42.7% of patients achieving consistent control of their condition.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!